Episode Details
Back to Episodes
FDA Approves First PCSK9 Pill for Cholesterol | US News
Description
FDA just approved Lipfendra, the first daily pill targeting PCSK9 to slash bad cholesterol—offering a cheaper, no-shot alternative to pricey injectables. At $315/month, it’s a game-changer for adults on max statins, slashing LDL by 56-59% in trials. Cardiologists are thrilled: this could make cholesterol control as routine as a daily statin, empowering primary care doctors and helping meet new heart attack/stroke prevention goals.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/c5d1e2e8803016a5